Based on our in vitro and in vivo results, we conclude that silencing LINC00482 could down-regulate the expression of MMP15 via targeting FOXA1, which results in the inhibition of proliferation, migration, invasion of bladder cancer. Here, FOXA1 is linked to urinary bladder cancer.